Watch the second annual Precision Health Virtual Summit powered by hc1 and Becker’s Healthcare

By Reed Richardson

Every year, adverse drug events lead to more than 3.5 million physician office visits, 1 million emergency department visits, and 125,000 hospital admissions, according to the U.S. Department of Health and Human Services’ Office of Disease Prevention and Health Promotion. Making sure patients take the right medication is critical to driving improved patient outcomes and reducing overall medical costs.

Imagine accessing an automated platform that can ingest patient claims data for any size population and show you which individuals have pharmacogenetic implications, are currently at risk to progress in their current disease state, and most likely to drive higher medical and pharmacy costs. Historically this kind of insight has been impossible to achieve.

With hc1 PGx Advisor™, not only can we identify the highest risk populations, we’ve also developed an end-to-end solution that can be easily integrated into operational workflows to provide a clear medication action plan to the prescribing physician(s) to drive change management and education at the patient level. The days of guessing which medication is going to treat which disease state for each specific individuals have been replaced with easy-to adopt workflows supported by clinical research that quickly address and react real-time to each individual’s needs.

Using our proprietary software to risk score everyone in a patient population based on their medication history, lifestyle, and pharmacogenomics drugs, we can identify those at risk for mismanagement of medications. We then deliver at-home pharmacogenomics tests to those individuals. Our cutting-edge lab partners analyze the specimens that the individuals send in and provide a specific review of each individual’s DNA. Once testing is completed, we add this patient-specific data to our software and have our team of pharmacists review the information to make recommendations that will reduce each patient’s risk score.

Why is this approach so important? it drives individual outcomes based on unique characteristics we all have as human beings. Not everyone . needs pharmacogenomics testing, but those with risk factors identified through our algorithm will benefit immediately from our pharmacist-to-physician interventions. To ensure that these interventions have occurred and change management has taken place, we continuously rescore the population based on the most current claims.

Physicians are the most pressured and busy professionals in healthcare. We here at hc1 recognize that if we are going to support them, we must be able to assist them without interrupting their daily routine. hc1 PGx Advisor is the solution to help them spend more time educating patients an less time worrying about medications. Enabling patient engagement that improves health and allows physicians more time to educate and build patient relationships is what we are most proud of with hc1 PGx Advisor.

Find out more about how hc1 PGx Advisor ensures the right patient gets the right test and right prescription. Request a demo.

Subscribe to the blog
Previous Post State PDMPs Alone Are Not Enough to Address the Opioid Epidemic—So What Is the Answer?
Next Post New Opioid Law Tests Common Lab Practices